Quantcast

Latest Clinical research Stories

2014-08-07 23:10:23

Peterson & Associates is assisting patients who have undergone morcellation during a hysterectomy or fibroid removal review and initiate their legal claims regarding cancer risks. KANSAS CITY, MO (PRWEB) August 07, 2014 Peterson & Associates, P.C., an experienced defective device litigation law firm, is investigating the cancer-risks posed by power morcellators. The firm is concerned about patient safety in light of FDA safety alerts and Johnson & Johnson’s worldwide...

2014-08-07 23:08:50

Leading beauty brand Makeover Essentials have recently had the quality of their makeup industry tested. Makeover Essentials are proud to announce the results of their cosmetic range have exceeded industry standards and been FDA approved, earning them a reputation for customer safety, quality and value. London (PRWEB) August 07, 2014 The results from the industry laboratory tests showed that Makeover Essentials are at 100% compliance with FDA requirements for cosmetic safety. The FDA or...

2014-08-07 16:28:03

The Approved Gleostine(TM) Brand Name has Replaced the Discontinued Former Drug Name CeeNu® MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "matured" and "innovative drugs" in today's global healthcare market. http://photos.prnewswire.com/prnvar/20140124/FL52230LOGO The product name change from Lomustine (CCNU) to Gleostine(TM) represents the...

2014-08-06 23:02:13

Published since 2006, the Orange Paper gives detailed snapshot of clinical trials in Russia. Moscow, Russia (PRWEB) August 06, 2014 Synergy Research Group has released its Q2, 2014 Orange Paper. Published since 2006, the Synergy Orange Paper gives an unbiased and detailed view of the state of clinical trials in Russia. The report, which is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies...

2014-08-06 12:29:33

SARASOTA, Fla., Aug. 6, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has made two key independent appointments to the Company's Board of Directors with the recent election of Ms. Lee M. Canaan, CFA and Mr. Edward J. McDonnell, MPH. as new directors. http://photos.prnewswire.com/prnvar/20140806/134113 Both Ms. Canaan and Mr. McDonnell have substantial expertise, experience and knowledge relevant to the Company's mission and...

2014-08-05 23:12:10

On July 25, CaCoCo Inc. informed consumers that CaCoCo “Original” and “Global Warrior” are recalled due to possible health risks. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on raw drinking chocolate. CaCoCo Inc. informed consumers on...

2014-08-05 23:03:14

OMICS Group International schedules its 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during September 29 to October 01, 2014 at Baltimore, USA with an aim to Revolutionize the Next Generation Medicines using innovative Bioavailability and Bioequivalence (BA/BE) approaches and Studies. Los Angeles, CA (PRWEB) August 05, 2014 Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile...

2014-08-05 12:31:12

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China,...

2014-08-05 08:33:41

Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide. ANN ARBOR, Mich. and DENVER, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Paradigm has announced today they have initiated genomic testing for Pharmatech's AccessPPM Cancer Registry. Pharmatech's AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials....

2014-08-05 08:33:24

QUÉBEC CITY, Aug. 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics(®) US, LLC, ("ASCEND"). Under the terms of the agreement, expected to start in the fourth quarter of 2014, Aeterna Zentaris will use its newly established commercial structure to market, in specific U.S. territories, ASCEND's EstroGel(® )a non-patch transdermal U.S. Food & Drug...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.